Timeline: Popular heartburn medicine Zantac pulled off store shelves
The U.S. Food and Drug Administration and international health authorities are investigating the safety of Zantac heartburn medicine, also sold generically as ranitidine, after finding a probable cancer-causing impurity https://www.reuters.com/article/us-fda-heartburn/fda-says-finds-unacceptable-level-of-carcinogen-in-zantac-and-its-generics-idUSKBN1WH1LA in the drug. (Source: Reuters: Health)
Source: Reuters: Health - October 3, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
FDA says finds 'unacceptable level' of carcinogen in Zantac and its generics
The U.S. Food and Drug Administration said on Wednesday it found "unacceptable levels" of a cancer-causing impurity in the popular heartburn drug Zantac and its generic versions known chemically as ranitidine. (Source: Reuters: Health)
Source: Reuters: Health - October 3, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
FDA determines toxicity levels in ranitidine ‘unacceptable’
The FDA has changed its story on whether or not the levels of a possible carcinogen in ranitidine are too high. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - October 2, 2019 Category: Pharmaceuticals Source Type: news
Walmart pulls Zantac amid growing worries over cancer link
Retailer is suspending all over-the-counter ranitidine products, including Zantac and Equate, following FDA alert (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - October 2, 2019 Category: Consumer Health News Source Type: news
FDA says new test finds 'unacceptable levels' of impurity in heartburn drugs
The U.S. Food and Drug Administration said on Wednesday it found "unacceptable levels" of a cancer-causing impurity in limited testing using low-heat method of samples of heartburn medicines such as Zantac containing the ingredient ranitidine. (Source: Reuters: Health)
Source: Reuters: Health - October 2, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
Walmart becomes latest U.S. retailer to pull heartburn drug Zantac
Walmart Inc on Wednesday became one of the last remaining major U.S. retailers to suspend the sale of over-the-counter heartburn medication containing ranitidine after the U.S. health agency flagged the presence of a probable cancer-causing impurity. (Source: Reuters: Health)
Source: Reuters: Health - October 2, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
Here's Why Zantac Was Pulled From Stores, And What You Should Do Now
Popular heartburn drug ranitidine was recalled for containing an impurity that may cause cancer. This is what experts want you to know. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - October 1, 2019 Category: Consumer Health News Source Type: news
Here ’s Why Zantac Was Pulled From Stores, And What You Should Do Now
Popular heartburn drug ranitidine was recalled for containing an impurity that may cause cancer. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - October 1, 2019 Category: Consumer Health News Source Type: news
CVS Halts Sale of Heartburn Treatment Zantac as FDA Warns of Contaminants
CVS has halted sales of popular heartburn treatment Zantac and its generic store brand after warnings by U.S. health regulators.
It’s the latest precautionary move by retailers and manufacturers after the U.S. Food and Drug Administration recently warned consumers about a potentially dangerous contaminant in prescription and over-the-counter versions of Zantac.
In its announcement this weekend, CVS said customers who bought Zantac products can return them for a refund. The retailer will continue to sell other heartburn medications.
What’s the issue?
In September, the FDA said it detected low levels of a probabl...
Source: TIME: Health - September 30, 2019 Category: Consumer Health News Authors: LINDA A. JOHNSON / AP Tags: Uncategorized medicine onetime Source Type: news
Bangladesh bans ranitidine
With regulatory bodies in the U.S. and EU investigating the presence of a probable carcinogen in ranitidine, Bangladesh has placed an outright ban on the popular heartburn drug. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 30, 2019 Category: Pharmaceuticals Source Type: news
CVS Halts Sales of OTC Zantac
MONDAY, Sept. 30, 2019 -- CVS is the latest drugstore chain to stop selling over-the-counter Zantac (ranitidine), as well as the store ' s own generic version of the heartburn medicine, because of contamination with a known carcinogen.
The U.S. Food... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 30, 2019 Category: Pharmaceuticals Source Type: news
CVS Pulls Zantac, Here Is The Latest On Cancer Concerns
If you bought these ranitidine products, you can return them as long as you have your very long receipt. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 30, 2019 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news
CVS Pulls Zantac And Similar Heartburn Drugs Over Cancer Concerns
(CNN) — CVS Pharmacy has stopped selling Zantac, as well as its generic version of the heartburn medication, over concerns that they might contain a substance that could cause cancer.
CVS, the largest pharmacy chain in the country, said over the weekend it was suspending sale of Zantac and other products which contain ranitidine until further notice. The US Food and Drug Administration said earlier this month that it has learned that some ranitidine — acid-reducing and heartburn medicines, including those known by the brand name Zantac — contain low levels of an impurity that could cause cancer.
Zantac an...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - September 30, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Featured Health News Syndicated CBSN Boston CVS Zantac Source Type: news
